The number of shares to be offered by either of the two companies and the price range for the proposed offerings have not yet been determined.
The new feature brings push health nudges and personalized health insights to smartphone users with chronic conditions.
The engine at the heart of this category is four pillars called AI+AI, which is the acronym for Aggregate, Interpret, Apply, and Iterate.
The new system allows blood pressure data to transfer seamlessly from "Cuff to Cloud," enabling easy checking and reporting from home.
Diabeto's technology makes it easier for people with diabetes to upload their blood glucose readings into Diabeto enabled systems, including Livongo's apps.
Previously Livongo's service was offered only through employers, health providers, and health plans; Livongo Family Care Plan changes that.
The company will use the funds to expand to other chronic conditions, and move to international markets.
Under the deal, the Livongo for Diabetes program will be offered with Voluntis' Insulia, an FDA-cleared medical device and app.
Just like your phone or tablet, Livongo's connected glucose meter will be able to receive software updates and bring along new capabilities.
Livongo combines human support, real-time data, and technology into a diabetes management program that truly engages participants.